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Abstract 
Prediabetes is an important risk factor for type 2 diabetes and cardiovascular complications, 
such as myocardial infarction. However, few studies explore female sex in this context. Here, 
we aim to investigate the effects of high-fat high-sucrose diet on cardiac parameters and 
sensitivity to ischemia-reperfusion injury of female Wistar rats. Female Wistar rats received 
for 5 months normal diet (CTRL group) or high-fat high-sucrose diet (HFS group). Every 
month MRI was performed to follow myocardial morphology, function and perfusion; cardiac 
and hepatic triglyceride content; and amount of sub-cutaneous and visceral adipose tissues. 
Then, ex vivo experiments were performed on isolated perfused hearts to evaluate tolerance to 
ischemia-reperfusion, with simultaneous measurement of energy metabolism by 
31
P MRS and 
contractile function. Coronary flow was measured before and after ischemia. At the end of the 
experiments, hearts were freeze-clamped for biochemical assays. Five months of high-fat 
high-sucrose diet induced a prediabetic condition in female Wistar rats, associated with an 
increase in myocardial perfusion, systolic and diastolic wall thickness. HFS rats also exhibited 
higher sensitivity to ischemia-reperfusion injury in comparison to controls, characterized by 
impaired cardiac function, energy metabolism and endothelial function. Biochemical analyses 
in hearts highlighted eNOS uncoupling, higher malondialdehyde level and lower S-
Glutathionylation of proteins in HFS rats, indicating higher oxidative stress. Prediabetes 
induced by energy-dense diet was associated with modification of cardiac morphology and 
higher myocardial sensitivity to ischemia-reperfusion injury. These results may be related to 
the high risk of cardiovascular complications among type 2 diabetic women. 
Key words: Prediabetes; High-fat high-sucrose diet; Female gender; Cardiac MRI; Ischemia-
reperfusion; Oxidative stress. 
1. Introduction 
Type 2 diabetes is worldwide recognized as a public healthcare issue affecting 425 million of 
people [1]. The leading cause of mortality and morbidity in type 2 diabetic patients remains 
cardiovascular (CV) complications. Interestingly, type 2 diabetes leads to CV complications 
[2] and mortality [3] more frequently in women than men. The risk of myocardial infarction is 
indeed 5 times higher in diabetic women than in non-diabetic women, whereas this risk 
increases only twice in men [2]. However, until now, only a small number of studies focus on 
female sex. 
Prediabetes, a condition characterized by increased fasting plasma glucose and/or intolerance 
to glucose, is also related to an increase of type 2 diabetes and CV risk [4]. Recently, the 
Maastricht study showed that there are already sex differences in  CV risk before the onset of 
type 2 diabetes, with more adverse cardiometabolic profile in prediabetic women [5]. During 
the transition from normoglycemia to impaired fasting glucose and type 2 diabetes, women 
present higher levels of endothelial factors and fibrinolytic / thrombotic factors than men, 
leading to greater endothelial dysfunction and insulin resistance [6]. The risk of heart and 
coronary disease is also higher at lower glucose levels in women [7]. Factors such as 
oxidative stress, inflammation, dyslipidemia and mitochondrial dysfunction can contribute to 
endothelial dysfunction, to microvascular and macrovascular damage, leading to CV 
complications [8]. Prediabetes is often associated with other risk factors of type 2 diabetes and 
CV diseases, such as abdominal obesity, hypertriglyceridemia, low HDL-cholesterol and 
raised blood pressure, clustered as metabolic syndrome (MetS) [9]. MetS is a strong predictor 
of the onset of type 2 diabetes with a higher risk of 52%. MetS could be responsible for 17% 
of CV events and 7 % of death by CV disease [10] and contributes to the increase by 78% of 
CV risk and death in MetS patients [11]. Therefore, more studies are needed to better 
understand prediabetic and metabolic syndrome conditions leading to higher CV risk in type 2 
diabetes, particularly in women. As prediabetes and metabolic syndrome are strongly 
associated with obesity [12], it becomes clear that our environment and life habits play an 
important role in the disease pathogenesis. The increased intake of western diet and the 
decrease of physical activity combined with genetic predisposition have strongly contributed 
to appearance and spreading of MetS [13].Thus, energy-dense-diet-induced animal model 
could help us explore CV complications of prediabetes and MetS conditions. 
The first objective of our study was to investigate the effect of a high-fat high-sucrose diet on 
cardiac morphology and function in parallel to the development of prediabetes in female rats, 
with a longitudinal follow-up in vivo using magnetic resonance imaging (MRI) and 
spectroscopy (MRS). The second objective was to assess the impact of high-fat high-sucrose 
diet on the sensitivity of heart during an ischemia-reperfusion injury, in which we combined 
measurement of myocardial and endothelial function with simultaneous evaluation of energy 
metabolism using 
31
P MRS. Finally, at the end of the experiments, we have explored cellular 
integrity, nitric oxide (NO) pathway, apoptosis and oxidative stress in the myocardial tissue to 
probe further into the molecular mechanisms induced by high-fat high-sucrose diet. To our 
knowledge, this is the first study to consider cardiac longitudinal follow-up and tolerance to 
ischemic insult in prediabetic female rats under high-fat high-sucrose diet, using MRI and 
MRS combined with biochemical analyses.  
2. Materials and Methods 
For details, see Supplementary Material. 
2.1 Animal model 
Seven-week-old female Wistar rats (around 170 g, Charles River, France) (n=20) were housed 
in a ventilated rack cabinet, with controlled temperature (22-24°C) and multiple 
environmental enrichments. All procedures involving animals were approved by the Animal 
experiment ethic committee of the University (APAFIS#10547-2017071009112930) and were 
performed in conformity with the Directive 2010/63/EU of the European Parliament on the 
protection of animals used for scientific purposes. Animals had access to food and water ad 
libitum. Female Wistar rats were divided randomly in two groups of 10: The control group 
(CTRL) was fed with standard diet (SAFE, A04C-10); and the HFS group was fed with high-
fat high-sucrose diet (SAFE, U8978 v19; composition detailed in Table 1). Rats received diets 
for five months, and weight and food intake were measured every week. Food efficiency was 
calculated as the ratio of weight gain on food intake over the 5 months of diet. 
2.2 Study design 
The experimental protocol is summarized in Figure 1. At 7 weeks of age, twenty female rats 
underwent an initial MRI/MRS investigation (T0). They were randomized into two groups 
(CTRL and HFS), and an MRI/MRS exam was performed on all rats every month. After 5 
months of diet, they underwent an intraperitoneal glucose tolerance test (IPGTT) to evaluate 
their metabolic status, and arterial blood pressure (BP) was measured. After sacrificing the 
animals, ex vivo experiments on isolated perfused heart were performed to assess myocardial 
function and tolerance to ischemia-reperfusion injury. At the end of the experiments, hearts 
were freeze-clamped for biochemical analyses. 
2.3 Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) investigations 
The MRI and MRS examinations were performed to evaluate in vivo cardiac morphology, 
cardiac function, myocardial perfusion, cardiac and hepatic triglycerides (TG) content and the 
amount of visceral (VAT) and subcutaneous (SCAT) adipose tissue in the body. All 
acquisitions were performed using a Bruker Biospec Avance MR system equipped with a 4.7 
Tesla magnet (Bruker, Ettlingen, Germany) and a proton volume resonator (diameter 60 mm; 
homogeneous length 80 mm).  
Before the experiments, rats were sedated by inhalation of 3.5% isoflurane. During MRI/MRS 
investigations, anesthesia was maintained at 1.5-2.5% isoflurane in 1 L/min pure oxygen-flow 
to obtain regular breathing at a rate of around 70 breaths per minute. Respiration, ECG signal 
and temperature were monitored during the whole procedure.  
Every month, an ECG-gated gradient-echo cine-MRI sequence (cine-FLASH) was used for 
the assessment of myocardial mass and function [14].
 
In vivo myocardial perfusion was 
quantified using the Arterial Spin Labeling (ASL) technique [15]. At 5 months, cardiac and 
hepatic 
1
H MR spectra were acquired for TG assessment using an ECG- and respiratory-gated 
Point-Resolved Spectroscopy (PRESS) sequence [16]. The TG/water signal ratio was 
calculated to obtain TG concentration. For a quantitative map of adipose tissue distribution, 
whole-body scanning was performed. Sixty-four contiguous axial imaging slices were 
selected across the animal body length excluding the tail [17, 18]. After each experiment, 
animals were kept alone under infrared light during wakefulness.  
2.4 Intra-peritoneal Glucose Tolerance Test (IPGTT) and Blood Pressure assessment at 
T5 months 
An IPGTT was performed after 6 hours of fasting to evaluate glucose homeostasis. Glycemia 
was measured before and 15, 30, 60, 90, 120 minutes after injection of a bolus of glucose, 
using ACCU-CHEK Performa Nano Glucometer (Roche, Switzerland).  
BP was recorded non-invasively by the tail cuff method (Bioseb, Chaville, France) [19]. 
2.5 Isolated perfused heart preparation and tolerance to ischemia-reperfusion injury 
Rats were anesthetized by intraperitoneal injection of 90mg/kg pentobarbital sodium. Hearts 
were cannulated and perfused in the Langendorff mode at constant pressure as described 
previously [20]. 
 
 
2.5.1 Experimental protocol 
After stabilization, hearts were perfused for 24 minutes with a physiological Krebs-Henseleit 
buffer containing 0.4 mM palmitate, 3% albumin, 11 mM glucose, 3U/L insulin, 0.8 mM 
lactate and 0.2 mM pyruvate. Before low-flow ischemia, they were perfused with 
physiological Krebs-Henseleit buffer containing 1.2 mM palmitate and then underwent a low-
flow ischemia (0.5 mL/min/g wet wt) of 32 minutes with the same buffer. A higher 
concentration of palmitate (1.2 mM) was provided during ischemia to cause maximal damage 
during ischemia and reperfusion [21]. Finally, flow was restored entirely for 32 minutes with 
the physiological Krebs-Henseleit buffer containing 0.4 mM palmitate. This protocol was 
previously reported to provide sufficient level of ischemia in a type 2 diabetic animal model 
[20]. 
2.5.2 Evaluation of myocardial function and energy metabolism  
A water-filled latex balloon was inserted in the left ventricle to record developed left 
ventricular pressure (DP) and heart rate (HR) [22]. The product of DP and HR (in 
mmHg/min) was used as an index of myocardial function. Coronary flow (CF) was measured 
by collection of coronary effluent before and after ischemia (at 20 minutes and 80 minutes of 
protocol). CF is expressed in mL/min/g wet weight. 
Energy metabolism was evaluated as previously described [23]. Briefly, perfused rat hearts 
were placed in a 20-mm magnetic resonance sample tube and inserted in a 4.7 Tesla magnet 
(Oxford instruments, Oxford, UK) interfaced with a Bruker-Nicolet Avance WP-200 
spectrometer (Bruker, Karlsruhe, Germany). A series of eight 
31
P NMR spectra were recorded 
during every period of the experimental protocol to quantify phosphorus metabolite signals 
(ATP, PCr and Pi) and intracellular pH.  
2.6 Dissection and collection of samples 
VAT, SCAT, tibia and blood were collected for evaluation of physiological parameters. At 
the end of the experiments, hearts were freeze-clamped in liquid nitrogen with a Wollenberger 
clamp and kept at -80°C for subsequent analysis. 
2.7 Biochemical analyses  
In plasma, assay kits were used to determine glucose (Randox Laboratories, Crumlin, Antrim 
UK), Free Fatty Acids (FFAs) (NEFA kit; Roche Diagnostics, Roche Applied Science, 
Mannheim, Germany), TG (Abcam, ab 65336), HDL- and LDL-Cholesterol (Abcam, ab 
65390). 
In freeze-clamped hearts, cellular integrity was evaluated by measurement of creatine kinase 
(CK) (CK-NAC, Randox Laboratories, Crumlin, UK) and lactate dehydrogenase (LDH) 
activities [23]; apoptosis with expression of cleaved caspase-3 by Western Blot [24]; NO 
pathway with the expression of total eNOS (endothelial NO synthase), P-eNOS 
(phosphorylated on Ser1177) and eNOS dimer-to-monomer ratio (eNOS d/m) by Western 
Blot [25, 26]; proteins post-translational modification with evaluation of S-Glutathionylation 
by Western Blot; and oxidative stress with assessment of Malondialdehyde (MDA), an index 
of lipid peroxidation, with the lipid peroxidation assay kit (MAK085, Sigma-Aldrich, St 
Louis, USA).  
2.8 Expression of results and statistical analyses 
Data are graphically provided as mean ± SEM of absolute values. Graph Pad Prism software 
5.0 (La Jolla, CA) was used for all statistical processing. Significant differences between 
groups were determined using two-way analysis of variance (ANOVA) with repeated 
measures over time for the time-dependent variables followed by Bonferroni post-hoc test. An 
unpaired Student’s t-test was used for the other parameters. Correlation analyses were also 
performed between imaging and other parameters. A p value of less than or equal to 0.05 was 
considered to indicate significant difference.  
3. Results 
3.1 Effect of high-fat high-sucrose diet on physiological parameters 
Physiological parameters are summarized in Table 2. Food intake was significantly lower in 
HFS versus CTRL during the whole diet (p<0.0001), while calorie intake and food efficiency 
were significantly increased (respectively p<0.001 and p<0.01). After 5 months of diet, the 
weight and the lean mass of animals was not different between groups, and neither systolic or 
diastolic arterial blood pressure. However, fat mass percentage was significantly higher in 
HFS vs. CTRL. Amount of VAT and SCAT measured by MRI was significantly higher at T5 
(p=0.014 and p=0.01, respectively), as well as VAT measured by dissection (p<0.05 vs. 
CTRL; p=0.08 for SCAT) in HFS vs. CTRL. Measurement by MRI and dissection were 
strongly correlated (VAT, r=0.98; SCAT, r=0.90). The percentage of cardiac TG was not 
different between groups, but the percentage of hepatic TG was significantly higher in HFS 
vs. CTRL at T5 (p<0.001). Heart weight-to-tibia-length ratio was similar in both groups. 
Plasma FFAs and fasting plasma glucose were significantly higher in HFS compared with 
CTRL (p<0.05 and p<0.01 respectively). No difference was found in plasma TG and HDL-
Cholesterol, but LDL-Cholesterol was significantly higher in HFS compared with CTRL 
(p<0.05). The IPGTT highlighted a significant glucose intolerance in HFS compared with 
CTRL (p<0.01). 
3.2 Effect of high-fat high-sucrose diet on cardiac morphology, perfusion and function  
The effects of high-fat high-sucrose diet on cardiac parameters are shown in Figure 2. The 
high-fat high-sucrose diet led to thickening of the myocardial wall in both diastole (p<0.01, 
Figure 2A) and systole (p<0.01, Figure 2B), and to increased left ventricular mass (p<0.05, 
Figure 2C) starting at the 3
rd
 month of diet in HFS vs. CTRL. Myocardial perfusion (Figure 
2D) was significantly increased in HFS (p<0.01) from T2 month vs. CTRL. However, the 
high-fat high-sucrose diet had no effect on cardiac function parameters (supplemental 
material) compared to CTRL.  
3.3 Effect of high-fat high-sucrose diet on myocardial tolerance to ischemia-reperfusion 
injury 
3.3.1 Ex vivo myocardial function and coronary flow 
Myocardial function (Figure 3A) evaluated by the product of DP and HR was significantly 
lower in baseline conditions (p<0.05) and during reperfusion (p<0.01) in HFS vs. CTRL. The 
percentage of recovery, expressed as percentage of control values, was significantly lower in 
HFS compared with CTRL (53 % ± 6 % vs. 29 % ± 6 %; p<0.05) during reperfusion. CF was 
not different between groups in baseline conditions (Figure 3B). However, CF was 
significantly lower in HFS vs. CTRL during reperfusion (p<0.05) (Figure 3C). 
3.3.2 Ex vivo energy metabolism and intracellular pH (pHi) 
Figure 4 shows kinetics of PCr (A), ATP (B), Pi (C) and pHi (D) during the ischemia-
reperfusion protocol. During the control period, no difference in PCr, ATP and Pi content was 
found between the two groups. During ischemia, PCr and ATP were significantly decreased in 
HFS compared with CTRL (p<0.05) and Pi was similar in both groups. During reperfusion, 
PCr and ATP were significantly decreased, and Pi was significantly increased in HFS vs. 
CTRL (respectively p<0.01, p<0.05 and p<0.05). pHi was similar in both groups during the 
whole protocol. 
3.3.3 Biochemical analyses in freeze-clamped hearts 
At the end of the ex vivo experiments, we studied NO pathway involved in the endothelial 
function. The expression of total eNOS and P-eNOS (Figures 5A and 5B) was similar 
between CTRL and HFS. However, we found an increase of uncoupled eNOS (inactive form) 
in HFS, characterized by significantly lower eNOS dimer-to-monomer ratio (Figure 5C) in 
comparison to CTRL (p<0.01), indicating an impaired endothelial function. Total S-
Glutathionylation (Figure 5D) of proteins was decreased (p=0.052) in HFS compared with 
CTRL, indicating a potentially diminished protection against oxidative stress. S-
Glutathionylation of eNOS (Figure 5E) was similar between groups. Malondialdehyde, a lipid 
peroxidation marker, was significantly increased in HFS vs. CTRL (p<0.05; 90.4 ± 6.3 vs. 
73.4 ± 4.7 nmol/g). 
Myocardial CK and LDH activities as markers of cellular integrity were similar in CTRL 
(11.03 ± 0.44 and 3.97 ± 0.28 U/mg protein) and HFS (10.65 ± 0.55 and 3.97 ± 0.25 U/mg 
protein) groups after ischemia-reperfusion injury. In both groups, the active form of caspase-3 
protein, was not expressed in hearts (data not shown) suggesting absence of apoptosis. 
3.4 Correlation analyses 
Correlation analyses are shown in Figure 6. FFAs, intrahepatic TG and percentage of 
functional recovery during reperfusion were correlated with the amount of VAT measured by 
MRI (respectively r²=0.68; r²=0.88 and r²=0.46). 
4. Discussion 
The aim of this study was to investigate the effects of long-term high-fat high-sucrose diet-
feeding i) on the development of prediabetes and/or metabolic syndrome (MetS), ii) on 
cardiac parameters and iii) on myocardial tolerance to ischemia-reperfusion injury in female 
Wistar rats. Here, the emergence of a prediabetic state combined with metabolic disturbances 
has led to cardiac remodeling characterized by thickening of the myocardial wall, and to 
increased myocardial perfusion. High-fat high-sucrose diet also decreased the sensitivity of 
the heart to ischemia-reperfusion injury characterized by an impairment of cardiac function, 
energy metabolism and endothelial function. Finally, biochemical analyses in heart tissue 
highlighted eNOS uncoupling, decreased S-Glutathionylation of proteins and increased MDA 
in HFS compared with CTRL, indicating exacerbated oxidative stress. 
Diet-induced models appear to be one of the best strategies to study prediabetic and MetS 
conditions associated with CV complications. In 2016, Wong et al. reviewed the different 
existing types of diet [27]. To get closer to human disease, Panchal et al. suggested to use a 
combination of fat- and carbohydrate-enriched diet, which groups a maximum of criteria and 
leads to cardiac dysfunction and hypertrophy in rats after 16 weeks of diet [28]. Here we used 
high-fat high-sucrose diet containing 19.4% of protein, 35.8% of fat and 32.1% of 
carbohydrate. After five months of diet, animals displayed the typical characteristics for 
diagnosis of prediabetes (higher fasting glucose and lower glucose tolerance), which were 
associated with metabolic disturbances that could lead to MetS and type 2 diabetes. While 
many studies [29] showed increased body weight in animals under various high-fat diets, we 
found that the weight of female HFS rats was not significantly increased in comparison with 
the control group. Aubin et al. reported the same observation in their study on female Sprague 
Dawley rats fed with HFD for 8 weeks [30]. Nishikawa et al. suggested that the female sex 
could be more resistant to high-fat diet-induced obesity, which could explain our results [31]. 
Also, food intake was lower in HFS rats, possibly because the high-fat high-sucrose diet was 
more caloric. Consistent with this explanation, an increase of serum leptin, the hormone 
regulating satiety, has been previously reported in rats under high-fat diet [32]. Despite a 
possible regulatory mechanism via leptin, HFS animals had a higher caloric intake leading to 
abdominal obesity. Indeed, HFS rats did not display weight gain but MRI and dissection 
highlighted an abdominal obesity with significant increase of fat mass percentage (of both 
VAT and SCAT). Multiple human studies have shown that waist circumference, an indicator 
of abdominal obesity, is more representative of total body fat than BMI [33]. Interestingly, the 
amount of VAT was correlated with changes in plasma FFAs and hepatic TG content. 
Moreover, VAT was also correlated to the percentage of functional recovery after ischemia-
reperfusion injury. These observations confirm that the anatomical distribution of excess fat is 
closely related to the occurrence of cardiovascular and metabolic complications [34], even in 
subject with normal weight [35]. Expansion and dysfunction of visceral adipose tissue both 
result in the release of fatty acids into the circulation and in ectopic fat deposition in organs 
like heart, liver or pancreas [36]. Here, we found an increase in plasma free fatty acids and 
LDL-cholesterol associated with an increase in intrahepatic TG content. The increase in 
myocardial TG content seems to occur later than the increase of hepatic TG content, as shown 
in male mice under high-fat high-sucrose diet [17]. This may explain why we found no 
difference between groups regarding cardiac TG content in this study. Finally, in this model 
we would expect an increase in arterial blood pressure, as described by Aubin et al. in female 
high-fat fed rats [30]. Here, only a non-significant tendency to elevated systolic and diastolic 
blood pressures was observed in the HFS group, warranting further investigation on a larger 
animal group. 
The combination of these risk factors predisposes women to CV complications. As shown by 
Levitzky et al. the risk of CV disease at lower glucose levels is higher in women than in men 
[7].
 
However, the mechanisms involved are not yet fully understood, and literature studies on 
female sex are scarce. Here, we followed female rats over months using cardiac MRI and 
observed multiple cardiac abnormalities. First, cardiac morphology was modified starting at 
the third month of diet with an increased myocardial wall thickness in systole and diastole. 
Left ventricular mass evaluated by MRI was increased at three and four months of high-fat 
high-sucrose diet.  Concentric remodeling may occur, for example, as a result of pressure 
overload (such as high blood pressure or aortic stenosis) whether or not there is ventricular 
hypertrophy (defined as an increase in mass) [37]. Cardiomyocyte hypertrophy and cardiac 
fibrosis [37] could also explain the cardiac remodeling found here. However, we note that 
heart weight to tibia length ratio obtained ex vivo was not significantly higher in HFS 
compared to CTRL. We attribute this apparent inconsistency to the difference in methodology 
of measurement in vivo and ex vivo. MRI evaluation of hypertrophy was based on an ellipsoid 
model [14] evaluating the left ventricle only. Ex vivo, we measured the weight of the entire 
heart just before cannulation, i.e. without potential biases by blood pressure and circulation. 
Dedicated histology experiments may help confirm this result in future studies. 
Left-ventricular cardiac function parameters evaluated by MRI were not different in female 
rats submitted to high-fat high-sucrose diet for 5 months compared with CTRL, whereas ex 
vivo basal cardiac function was significantly weaker. The in vivo cardiac function 
measurements reflect dynamic volume measurements whereas ex vivo function reflects 
pressure developed during contraction. Also, ex vivo cardiac function is not submitted to the 
effective regulations and demands in vivo.  A similar difference between in vivo and ex vivo 
cardiac function was found by Cole et al., who found normal cardiac function in vivo in rats 
submitted to high-fat diet but 21% decreased cardiac efficiency ex vivo compared with 
controls [38]. They related the lower cardiac efficiency to an increase in myocardial oxygen 
consumption. In our study, along with cardiac function we monitored myocardial perfusion in 
vivo, which may be linked to oxygen consumption. Interestingly, myocardial perfusion was 
significantly higher in HFS vs. CTRL, despite normal in vivo cardiac function, consistent with 
the study by Cole et al. We thus hypothesized that HFS hearts needed higher capillary blood 
flow to produce the same work indicating decreased cardiac efficiency. Moreover, increased 
myocardial perfusion might be a transient condition found in prediabetic animals [39]. In fact, 
a previous study in our laboratory showed decreased myocardial perfusion in type 2 diabetic 
male mice under high-fat high-sucrose diet [17]. Also, Iltis et al. showed defective myocardial 
blood flow in 8-13 months type 2 diabetic GK rats [40]. Then, it would be interesting to test 
this diet over a longer period to evaluate whether myocardial perfusion decreases below 
normal values at later stages in this model as well. Another study in type 1 diabetic patients 
reported higher myocardial perfusion at rest than in healthy controls [41]. Finally, it is well 
known that myocardial perfusion can be modified by isoflurane concentration, temperature or 
heart rate, and that perfusion values likely reflect partial vasodilation [42]. However, these 
parameters were monitored during the MRI exam and were not different between the groups 
(data not shown). 
In summary, 5 months of high-fat high-sucrose diet induced modification of cardiac 
morphology and efficiency. Using the ischemia-reperfusion ex vivo protocol, we further found 
higher sensitivity to ischemia-reperfusion injury in HFS compared with CTRL, characterized 
by a significant decrease in myocardial function and energy metabolism during reperfusion. 
Under physiological conditions mitochondria play a fundamental role in oxidative catabolism 
leading to the production of energy in the form of ATP. Multiple mitochondrial impairments 
could be responsible for lower energy metabolism. Among these are mitochondrial 
uncoupling [38], decreased expression of mitochondrial respiratory chain complex or 
increased ROS production. Moreover, a loss of nucleotide precursors limiting ATP repletion 
during reperfusion could contribute to our observation. Because these alterations may be 
correlated with oxidative stress, we particularly focused on myocardial MDA content as lipid 
peroxidation marker, which was significantly higher in HFS vs. CTRL. Pakdeechote et al. 
have previously reported higher vascular superoxide production as well as higher MDA levels 
in plasma in metabolic syndrome rats [43]. Poudyal et al. also showed lowered capacity to 
neutralize free radicals characterized by the decrease of antioxidant capacity [29]. Finally, 
ischemia and mostly reflow are well-known to induce high oxidative stress, which is 
exacerbated here by the 5-month high-fat high-sucrose diet. We also assessed the S-
Glutathionylation of proteins, which is the reversible addition of glutathione to cysteine 
residues inactivating the target proteins [44], and which could be involved in CV 
complications [45]. Protein S-Glutathionylation occurs mainly at the beginning of reflow in 
an ischemia-reperfusion protocol and has been shown to be increased in some studies. For 
example, De Pascali et al. showed an increase in eNOS S-Glutathionylation during ischemia-
reperfusion injury in endothelial cells [46]. However, Belcastro et al. explained that S-
Glutathionylation can also be a protective mechanism coping with irreversible oxidation [45]. 
This would explain the lower rate of S-Glutathionylation found here in HFS vs. CTRL. We 
have shown that S-Glutathionylation of all the proteins was significantly decreased in HFS 
compared with CTRL, but we found no difference in specific S-Glutathionylation of eNOS. 
Here, we suggest that S-Glutathionylation was decreased by high-fat high-sucrose diet, 
leading to higher level of damage by oxidative stress in hearts. This result was consistent with 
the higher MDA heart content mentioned before. 
Prediabetes and MetS increase the risk of cardiovascular events and have a deleterious impact 
on endothelial function with enhanced coronary artery disease prevalence [47]. Altered 
vasodilatation has been previously described. Poudyal et al. showed lower vascular response 
to noradrenaline, acetylcholine and sodium nitroprusside in a MetS model [29] while 
Senaphan et al. found decreased eNOS expression in mesenteric arteries [48]. Here, no 
significant difference was found in coronary flow before ischemia. During reperfusion, 
however, coronary flow was significantly impaired in HFS vs. CTRL, indicating higher 
sensitivity of coronary arteries to ischemia-reperfusion injury. We found no difference 
between the groups concerning the expression of total eNOS or its phosphorylated form. 
However, we found higher eNOS uncoupling in HFS compared with CTRL, with a lower 
dimeric (active) form of eNOS and a higher monomer form of eNOS in hearts, indicating that 
high-fat high-sucrose diet impaired eNOS activity. eNOS uncoupling is known to be 
responsible for the increase in superoxide anion O2
.-
 production instead of NO [49]. O2
.- 
is 
highly deleterious for the cells and can also react with NO to form peroxynitrite (ONOO
-
), 
making it less available for endothelial function. ONOO
- 
has been shown to inhibit 
mitochondrial respiratory chain complex [50]. During reperfusion this phenomenon is 
amplified because the free electrons couple to oxygen to form O2
.-
. Moreover, patients with 
MetS show lower levels of superoxide dismutase able to handle superoxide anion [51]. 
Endothelial function also seems to be a key point in cardiac complications of type 2 diabetes. 
Desrois et al. showed endothelial impairment in female Goto-Kakizaki rats, with lower 
coronary flow and reduced up-regulation of the NO pathway [22]. Zhang et al. revealed a 
predisposition of females to vascular lesions after induction of diabetes, in the mesenteric 
arteries [52] and the aorta [53]. Thus, endothelial dysfunction found in our model of 
prediabetes could be related to the higher cardiovascular risk in prediabetic and type 2 
diabetic women. 
As a perspective, it would be interesting to measure plasma hormones in order to fully 
elucidate their role in high-fat high-sucrose diet-induced cardiovascular modifications. 
Baseline cardiac function differs between sexes in terms of heart rate, systolic output, ejection 
fraction [54]. Studies on rodents [55] have shown that cardiac myocytes of male rats contract 
stronger and faster than the myocytes of female rats. Estrogen receptors (ERα and β) are both 
found in cardiomyocytes and may have a strong impact on cardiovascular function [56]. 
Estrogens have been shown to protect the heart from ischemic injury [57]. The loss of 
estrogens also leads to aggravation of mitochondrial dysfunction, inflammation and cardiac 
remodeling [58]. Sex hormones could also explain the differences found in endothelial 
function, as reported by Khalil et al., who showed that estrogen might directly stimulate NO 
production in women [59]. Interestingly, Al-Mulla et al reported a decrease in estrogens and 
an increase in testosterone levels in the GK rat model [60]. However, in a model of high-fat 
diet, Chakraborty et al. reported an increase in estradiol level with high-fat diet [61]. In 
addition, assessing the cytokine profiles in HFS rats could help us understand diet-induced 
metabolic and structural changes that occur before ischemia-reperfusion injury. Indeed, 
Pakdeechote et al. reported higher plasma TNFα and increased expression of iNOS in aorta of 
rat with diet-induced metabolic syndrome [43]. In future studies it would also be interesting to 
have dedicated groups for histology investigations. Previous studies showed that 16 weeks of 
high-carbohydrate high-fat diet could induce cardiomyocyte hypertrophy, as well as left 
ventricular interstitial collagen deposition and inflammatory cell infiltration in rat hearts [29, 
37, 62]. Finally, dietary interventions could prevent cardiac changes observed in prediabetic 
female rats.  Abdurrachim et al. showed that intermittent fasting could delay the progression 
of left ventricular hypertrophy and prevent cardiac dysfunction in prediabetic obese 
spontaneous hypertensive heart failure rats, by modulating cardiac substrate metabolism [63]. 
Alam et al. showed for example that chronic L-Arginine treatment improved metabolic, 
cardiovascular and liver complications in diet-induced obesity in rats [62]. We also believe 
that an antioxidant approach would be of great interest in our context. For example, 
Resveratrol, a polyphenol, well-known for its anti-oxidant property, can protect the heart of 
high-fat fed rats [64].  
5. Limitation of the study 
One limitation of our study might be the absence of male groups, which could help us 
demonstrate sex-specific response to high-fat high-sucrose diet on cardiovascular alterations. 
However, we believe this is an original study on female sex which is little explored in the 
literature. Indeed, most of the studies use male population only, although type 2 diabetic 
women have a higher cardiovascular risk than type 2 diabetic men. Here, our objective was to 
study the female population by performing a longitudinal follow-up at the beginning of the 
disease and to observe the early adaptation of the heart to prediabetes. It brings new insights 
on cardiovascular complications in female rats during the development of prediabetes, with 
increased myocardial perfusion as well as high sensitivity to ischemia-reperfusion injury via 
impaired energy metabolism, S-Glutathionylation and eNOS uncoupling. 
6. Conclusion 
To our knowledge, this is the first study combining a longitudinal cardiac MRI follow-up with 
an assessment of tolerance to ischemic insult in prediabetic female rats under high-fat high-
sucrose diet. In female rats, prediabetes led to myocardial adaptation over months 
characterized by thickening of the myocardial wall and increase in myocardial perfusion. It 
also led to higher cardiac sensitivity to ischemia-reperfusion injury. Oxidative stress seems to 
be at the intersection of the pathways elucidated here, as shown in Figure 7. Oxidative stress, 
induced by ischemia-reperfusion, was exacerbated under high-fat high-sucrose diet. Here, it 
might be responsible for i) cardiac dysfunction via impaired energy metabolism with altered 
ATP and PCr production during ischemia-reperfusion injury, ii) endothelial dysfunction via 
eNOS uncoupling and decreased NO bioavailability leading to lower coronary flow, and iii) 
decrease of protective protein S-Glutathionylation mechanism. This work provides insights 
that may contribute to understanding the cardiovascular complications related to prediabetes 
and type 2 diabetes in the female sex. 
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Compounds % 
Casein 22.8 
DL methionine 0.2 
Maltodextrin 17.15 
Sucrose 16.64 
Anhydrous butter 33.35 
Soya oil 2.5 
Mineral (AIN  93G-mx) 4.55 
Sodium bicarbonate 1.05 
Potassium citrate 0.4 
Vitamin (AIN 93-vx) 1.3 
Choline bitartrate 0.2 
Antioxidant 0.002 
 
Table 1: Composition of the high-fat high-sucrose diet (SAFE, U8978).  
 CTRL HFS note 
Body weight (g) 270.1 ± 11.2 297.8 ± 17.3  
Lean mass (g) 262.8 ± 7.4 271.7 ± 9.1  
Food intake for 5 months (g) 1514 ± 26 1031 ± 10.8 * 
 
Calories intake for 5 months (kcal) 5054 ± 87 5669 ± 59 *  
AUC Food efficiency (weight 
gain/food intake)  
0.31 ± 0.04 0.50 ± 0.05 † 
 
Systolic blood pressure (mm Hg) 111.7 ± 3.3 128.7 ± 10.4  
Diastolic blood pressure (mm Hg) 76.1 ± 2.9 90.1 ± 8.1  
VAT MRI (volume mm
3
/slice) 700 ± 63 1122 ±128 ‡ Correlation 
r²=0.90 
VAT Dissection (g) 19.3 ± 3.1 38.4 ± 6.7 ‡ 
SCAT MRI (volume mm
3
/slice) 233 ± 13 402 ± 52 † Correlation 
r²=0.98 
SCAT Dissection (g) 9.89 ± 1.5 18.9 ± 4.3 
Cardiac TG (%) 0.28 ± 0.28 0.14 ± 0.14  
Fat mass (%) 9.8 ± 1.2 16.8 ± 2.1 ‡  
Hepatic TG (%) 0.88 ± 0.28 6.10 ± 1.27 *  
Heart weight (g) 0.76 ± 0.02 0.78 ± 0.02  
Tibia length (cm) 3.50 ± 0.04 3.48 ±0.04  
Heart weight / Tibia length (g/cm) 0.220 ± 0.005 0.230 ± 0.006  
FFAs (mM) 0.09 ± 0.01 0.21 ± 0.04 *  
Fasting glucose (mM) 4.78 ± 0.22 5.72 ± 0.17 †  
TG (mM) 125.2 ± 14.4 90.5 ± 15.2  
HDL-Cholesterol (mM) 1.24 ± 0.07 1.24 ± 0.13  
LDL-Cholesterol (mM) 0.83 ± 0.10 1.19 ± 0.13 ‡  
AUC IPGTT (mM/min)  7.1 ± 0.5 10.4 ± 0.8 †  
Table 2: Physiological characteristics of rats after 5 months of diet. Data are means ± 
SEM, two-way ANOVA was used for statistical analysis of IPGTT and t-test was used for all 
the other parameters. HFS group had lower food intake, higher calorie intake, food efficiency, 
amount of visceral and subcutaneous adipose tissue, % of fat mass, % of hepatic TG, plasma 
FFAs, fasting glucose, LDL-Cholesterol and intolerance to glucose. We found no difference 
between groups for body weight, systolic blood pressure, diastolic blood pressure, cardiac TG 
content, heart weight-to-tibia length ratio, plasma TG and HDL-Cholesterol.  AUC: area 
under the curve. * p<0.001; † p<0.01 and ‡ p<0.05 vs. CTRL. 
Figure 1 
 
 
Figure 1: Experimental protocol. At 7 weeks of age, animals (n=20) underwent a first 
MRI/MRS investigation (T0). Female Wistar rats were randomized in two groups (CTRL and 
HFS), and every month an MRI/MRS exam was performed on each rat. The following 
parameters were evaluated: myocardial morphology, function, perfusion, triglyceride content, 
hepatic triglycerides and visceral and subcutaneous adipose tissue amount. After 5 months of 
diet, rats underwent an intraperitoneal glucose tolerance test (IPGTT) to evaluate their 
metabolic status, and arterial blood pressure (BP) was measured. Then, ex vivo experiments 
on isolated perfused heart were performed to evaluate tolerance to ischemia-reperfusion injury 
with simultaneous measurement of myocardial function, energy metabolism and coronary 
flow. At the end of the experiments, hearts were freeze-clamped for biochemical analysis. 
Western blots were performed to analyze expression of eNOS, P-eNOS, eNOS 
dimer/monomer, S-Glutathionylation, eNOS S-Glutathionylation and Caspase-3 proteins. 
Colorimetric assays were performed to assess MDA heart content and activity of creatine 
kinase and lactate dehydrogenase enzymes. 
  
Figure 2: Monitoring of cardiac morphology and perfusion over time by MRI. Diastolic 
myocardial wall thickness (Wtdia) (A), Systolic myocardial wall thickness (Wtsys) (B), Left 
ventricular mass (LVMass) (C), Myocardial perfusion (D). Data are means ± SEM. Two-way 
ANOVA was performed to observe the effect of group and time. Wtdia (ANOVA: p<0.01; 
Bonferroni post-hoc test: T3 p<0.001, T4 p<0.001 and T5 p<0.05) and Wtsys (ANOVA: 
p<0.01; Bonferroni post-hoc test: T3 p<0.01, T4 p<0.01 and T5 p<0.05) were significantly 
increased in HFS vs. CTRL from the third month. LVMass was significantly increased in 
HFS at T3 and T4 months (ANOVA: p<0.05; Bonferroni post-hoc test: T3 p<0.05 and T4 
p<0.01). Myocardial perfusion was significantly increased from the second month of diet 
(ANOVA: p<0.01; Bonferroni post-hoc test: T2 p<0.05, T3 p<0.01 and T5 p<0.05). * p<0.01 
and † p<0.05 vs. CTRL (Two-way ANOVA). 
  
Figure 3: Ex vivo evaluation of myocardial function. Myocardial function (A) was 
evaluated by the product of developed pressure and heart rate, during the experimental time 
course in CTRL and HFS rat hearts. Coronary flow was measured during the control period at 
20 minutes (B) and during reperfusion at 80 minutes (C) of protocol. Results are expressed as 
means ± SEM. For myocardial function statistical analysis, two-way ANOVA was performed 
to observe the effect of group and time. T-test was performed for statistical analysis of 
coronary flow. In HFS, myocardial function was significantly decreased during the control 
period and reperfusion, % of recovery and coronary flow were significantly impaired 
compared with CTRL. * p<0.05 and † p<0.01 vs. CTRL. 
  
Figure 4: Ex vivo evaluation of energy metabolism with 
31
P-MRS. Kinetics of 
phosphocreatine (PCr) (A), ATP (B), Pi (C) and intracellular pH (pHi) (D) during the 
experimental time course in CTRL and HFS rat hearts. Data are means ± SEM. Two-way 
ANOVA was performed to observe the effect of group and time. Myocardial PCr and ATP 
contents were significantly decreased in HFS vs. CTRL during low-flow ischemia and 
reperfusion. Pi was significantly increased in HFS compared with CTRL only during 
reperfusion. pHi was similar in both groups during the whole protocol. * p<0.05 and † p<0.01 
vs. CTRL (Two-way ANOVA). 
  
 Figure 5: Biochemical analysis in freeze-clamped hearts at the end of ischemia-
reperfusion injury. Determination of protein expression of total eNOS (A), P-eNOS (B), 
eNOS dimer-to-monomer ratio (C) and determination of S-Glutathionylation of total (D) and 
eNOS (E) proteins by western blot. Data are means ± SEM and t-test was used for all the 
parameters. No difference was found between groups for expression of eNOS, and P-eNOS; 
eNOS uncoupling was significantly higher in HFS vs. CTRL. No difference was found 
between groups regarding eNOS, P-eNOS expression and S-Glutathionylation of eNOS. The 
ratio eNOS d/m was significantly decreased in HFS vs. CTRL, indicating eNOS uncoupling. 
S-Glutathionylation of total proteins was also decreased in HFS vs. CTRL. * p< 0.05 vs. 
CTRL; † p< 0.05 vs. CTRL.  
 
 
Figure 6: Correlation analysis between imaging and outcomes. Plasma FFAs (A) and 
hepatic TG content (B) were correlated to the amount of VAT measured by MRI. Percent of 
functional recovery during reperfusion was also correlated to the amount of VAT (C).  
 
 
 
Figure 7 
 
Figure 7: Potential mechanisms involved in the lower tolerance to ischemia-reperfusion 
in prediabetic female rats. High-fat high-sucrose diet (HFS) increased sensitivity to 
ischemia-reperfusion injury ex vivo. Oxidative stress was exacerbated, with higher MDA 
level, eNOS uncoupling and lower protection mechanism by S-Glutathionylation in female rat 
hearts. It might explain the impaired energy metabolism and endothelial function leading to 
cardiac dysfunction in female gender. ℗: Protein; MDA: Malondialdehyde.   
  
Supplementary material 
MRI/MRS investigations 
Animals were placed prone on an actively decoupled surface coil (diameter 30mm, Rapid 
Biomedical, Rimpar, Germany) used for radiofrequency reception. The cardiac region of the 
thorax was placed at the isocenter of the coil. For assessment of the amount of visceral and 
subcutaneous adipose tissue in the body the proton volume resonator was used for both 
radiofrequency transmit and receive. Respiration was monitored using a pressure sensor 
connected to an air-filled balloon positioned under the rat abdomen. Body temperature was 
maintained at 37°C using a warming blanket positioned on the back of the animal. The 
Electrocardiogram (ECG) signal was monitored by two subcutaneous electrodes placed on the 
upper limbs of the rats. The electrodes were connected to an ECG trigger unit (Rapid 
Biomedical, Rimpar, Germany) to estimate the heart rate (HR) and to trigger the MR 
sequences. 
Myocardial function and mass 
 We acquired strictly perpendicular slices in two- and four-chamber long-axis orientation and 
short-axis orientation at mid-ventricular level (FLASH, field of view, 4 x 4 cm²; slice 
thickness = 2 mm; matrix size = 128 x 128; TR = 5.1 ms; TE = 1.2 ms; 45 phases per cardiac 
trigger). Image post processing was performed using an in-house developed program running 
under an IDL environment (Interactive Data Language, ITT Visual Solutions, Boulder, CO, 
USA). Left ventricular volumes were determined using an ellipsoid model. Endocardial and 
epicardial areas were manually delineated on short-axis images, with ventricular lengths 
determined from four-chamber long-axis views in diastole and systole respectively. End-
diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), left ventricular 
ejection fraction (LVEF), mean wall thicknesses in diastole (Wtdia) and systole (Wtsys), and 
systolic wall thickening (sWtn) were calculated from the volume measurements. Cardiac 
output (CO) was calculated as CO = HR x SV, and Cardiac Index (CI) = CO / Body weight. 
Myocardial perfusion 
An ECG and respiration-gated Look-Locker gradient-echo flow-sensitive alternating 
inversion recovery ASL technique was used to acquire two T1 maps from a single short-axis 
slice placed at the ventricular mid-level, one after a slice selective inversion pulse and one 
after global inversion pulse. The following parameters were used: field of view = 4 x 4 cm²; 
slice thickness = 3 mm; matrix size = 128 x 64; train of 50 gradient echoes; flip angle = 12°. 
Image analysis was performed using a home-made program running under IDL environment 
which generated absolute myocardial blood flow (MBF) maps. MBF, expressed in mL/g/min, 
was determined as average of pixel values in manually delineated regions of interest in the 
entire left ventricular myocardium on the corresponding MBF maps. 
Cardiac and hepatic TG 
The measurement of TG fraction with MRI has been previously validated in our laboratory 
and was correlated with TG content measured by biochemical analyses.  
Voxels were positioned using the short-axis and four-chamber view cine scans as reference. 
The volume of interest had a size of 1 x 1 x 2 mm
3
 and was placed in the basal region of the 
septum. Acquisitions were done in the systolic phase. The following parameters were used: 
number of averages (NA) = 512, repetition time equal to the respiratory interval (about 
800ms). A second scan was acquired to obtain an unsaturated water peak as reference (TR = 5 
s; NA = 64).  Molecular content of water was quantified by integration of the resonances at 
4.7 ppm and triglycerides at 1.3 ppm in time domain (AMARES fitting). In the liver, a larger 
voxel size (2 x 2 x 2 mm3) was used to reduce scan time. It was placed in the anterior part of 
the liver. Parameters were TR = Respiratory interval (about 800ms) and NA = 128. For the 
reference scan parameters were TR = 5 s and NA = 32. Liver TG were quantified using 
PRESS with respiratory gating only. 
VAT and SCAT 
For a quantitative map of adipose tissue distribution, whole-body scanning was performed. 
Sixty-four contiguous axial imaging slices were selected across the animal body length 
excluding the tail. Magnetic resonance images of these slices were recorded using a high-
resolution three-dimensional (turbo spin echo) sequence with the following parameters: TE = 
5.543 ms; effective TE = 88.69 ms; TR = 350 ms; NA = 2; field of view = 80 x 60 x 70 mm
3
; 
matrix size = 128 x 128 x 64. MR data were processed using a custom-written analysis 
program developed with the IDL software. Quantification of both VAT and SCAT was 
performed using an automatic segmentation method based on a pixel intensity analysis of MR 
images.  
  
Isolated perfused heart 
Energy metabolism assessment by 
31
P magnetic resonance spectroscopy – Quantification of 
phosphorus metabolites and determination of intracellular pH. 
31
P spectra were obtained by accumulating 328 free induction decay signals acquired for 4 
minutes (flip angle 45°, repetition time 0.7 s, spectral width 4500 Hz, 2,048 data points). 
Quantification of the signal integrals was carried out using an external reference containing an 
aqueous solution of 0.6 mM phenylphosphonic acid. 
Biochemical analyses in freeze-clamped heart 
Apoptosis 
The expression of cleaved caspase-3 (active form) was determined in heart homogenates by 
Western Blot. Samples (50 µg) were run in Tris-Glycine-SDS with 4-20% gradient gel (Bio-
Rad, Mini-PROTEAN TGX, Precast Gels) and transferred to pure nitrocellulose membrane 
(0.45 µm, Bio-Rad) with a semi-dry transfer device (Transblot SD system, Biorad). After 
blocking, membranes were incubated overnight at 4°C with primary anti-rabbit antibody 
against Caspase-3 (1/1000; Cell Signaling Technology, Inc, USA) and secondarily with HRP-
conjugated anti-rabbit antibody (1/2000; Santa Cruz Biotech). 
NO pathway 
The expression of total eNOS, eNOS -PSer1177 and eNOS dimer-to-monomer ratio (eNOS 
d/m) were determined in heart homogenates by Western Blot. Proteins were separated by gel 
electrophoresis and transferred onto PVDF membranes. After blocking, membranes were 
incubated overnight at 4°C with primary antibody: anti-mouse eNOS (1/1000 for eNOS and 
eNOS d/m, BD Biosciences), anti-mouse eNOS-Pser1177 (1/1000, BD Biosciences); and 
secondarily with HRP-conjugated antibody. 
Post-translational modification of proteins 
S-Glutathionylation of proteins was evaluated by Western Blot. Protein samples (80µg) were 
run in SDS-PAGE (8%) and transferred to PVDF membrane. After blocking, membranes 
were incubated with primary anti-mouse antibody against Glutathione (1/500; Santa Cruz 
Biotech) and secondarily with HRP-conjugated antibody (1/5000; BD Bioscience). eNOS S-
Glutathionylation was determined by stripping and incubating the same membrane with 
primary anti-mouse antibody against eNOS as described above.  
Table 2: Cardiac function parameters measured by MRI after 5 months of diet in CTRL and 
HFS. Results are expressed as means ± SEM. 
 
 
Western Blot used for figure 5 
 
 
 
 
 
 
 
 
CTRL HFS 
LVVdia (µL) 890 ± 26 948.9 ± 34.5 
EDV (µL) 403.6 ± 16.5 397 ± 14 
LVVsys (µL) 666.5 ± 20.9 719 ± 32 
ESV (µL) 114 ± 9 98.1 ± 11.6 
SV (µL) 289.6 ± 9.9 298.5 ± 7.3 
EF (%) 72 ± 1 76 ± 2 
CO (mL/min) 109.3 ± 5.7 128.4 ± 3.8 
CI (µL/min/g) 408.7 ± 23.3 453.9 ± 31.3 
eNOS 
GAPDH 
CTRL  HFS   CTRL   HFS   CTRL  HFS  CTRL   HFS   CTRL 
CTRL   HFS   CTRL   HFS   CTRL   HFS    CTRL   HFS   CTRL 
  
 
 
 
 
 
 
 
 
 
 
eNOS d 
 
eNOS dimer (280 kDa) 
eNOS monomer (140 kDa) 
HFS CTRL   CTRL HFS  CTRL HFS CTRL HFS 
P-eNOS 
eNOS 
CTRL  HFS   CTRL   HFS   CTRL  HFS  CTRL   HFS   CTRL 
CTRL   HFS   CTRL   HFS    CTRL   HFS     CTRL    HFS    CTRL 
eNOS S-Glut 
CTRL HFS CTRL HFS    CTRL HFS             CTRL HFS 
CTRL  HFS  CTRL  HFS    CTRL HFS             CTRL HFS CTRL 
Glutathionylated proteins 
